Bharath Hospital & Institute of Oncology

Mysore, Karnataka 570 017

0 studies enrolling now · 1 studies all time

What they study most

Multiple Myeloma

Studies at this site

• Study of Mapatumumab in Combination With Bortezomib (Velcade) and Bortezomib Alone in Subjects With Relapsed or Refractory Multiple Myeloma — Completed